(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 구조식 이미지
카스 번호:
34279-77-1
상품명:
(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
동의어(영문):
Cephamycin B;(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CBNumber:
CB92316661
분자식:
C25H29N3O11S
포뮬러 무게:
579.57626
MOL 파일:
34279-77-1.mol

(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 속성

안전

(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid C화학적 특성, 용도, 생산

(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 준비 용품 및 원자재

원자재

준비 용품


(6R,7S)-7α-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-3-[[[3-(4-hydroxyphenyl)-2-methoxy-1-oxo-2-propenyl]oxy]methyl]-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 공급 업체

글로벌( 3)공급 업체
공급자 전화 이메일 국가 제품 수 이점
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14055 65
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628
jiangnan@huidabiotech.com China 3656 58
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639
sunshixuan@huidabiotech.com China 3705 58

Copyright 2019 © ChemicalBook. All rights reserved